CASI Pharmaceuticals, Inc. (CASIF)
OTCMKTS · Delayed Price · Currency is USD
0.1300
+0.0225 (20.93%)
At close: Jun 5, 2026
CASI Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -48.06 | -39.26 | -26.94 | -41.01 | -36.65 |
Depreciation & Amortization | 1.26 | 2.33 | 3.74 | 2.42 | 1.82 |
Loss (Gain) From Sale of Assets | 0.01 | -0.48 | - | 2.06 | 0.07 |
Asset Writedown & Restructuring Costs | - | 0.7 | - | 8.72 | 6.56 |
Loss (Gain) From Sale of Investments | 0.18 | -1.7 | 2.59 | 3.57 | -4.8 |
Loss (Gain) on Equity Investments | 2.19 | 1.19 | 0.05 | 0.85 | - |
Stock-Based Compensation | 2.99 | 1.31 | 7.22 | 7.01 | 7.77 |
Other Operating Activities | 2.19 | 5.92 | 1.19 | 1.95 | 1.62 |
Change in Accounts Receivable | 11.25 | -5.79 | 3.42 | -3.17 | -5.16 |
Change in Inventory | 2.51 | 5.83 | -9.74 | -4.23 | -0.55 |
Change in Accounts Payable | -1.66 | -1.72 | 1.15 | 1.07 | 1.49 |
Change in Income Taxes | - | - | -1.89 | 1.98 | - |
Change in Other Net Operating Assets | 6.4 | 2.45 | -0.76 | -2.3 | 1 |
Operating Cash Flow | -20.75 | -29.22 | -19.97 | -21.09 | -26.84 |
Capital Expenditures | -0.02 | -0.22 | -0.2 | -5.61 | -8.95 |
Sale of Property, Plant & Equipment | - | - | - | 0.14 | 0.01 |
Sale (Purchase) of Intangibles | -0.01 | 0.48 | -2.04 | - | -6.56 |
Investment in Securities | 0.98 | 10.98 | -8.43 | 30.2 | - |
Other Investing Activities | - | - | - | 6.44 | 0.47 |
Investing Cash Flow | 0.95 | 11.24 | -9.67 | 31.16 | -20.69 |
Short-Term Debt Issued | 6 | - | - | 4 | 0.71 |
Total Debt Issued | 6 | - | - | 4 | 0.71 |
Short-Term Debt Repaid | - | - | - | -4 | -1.55 |
Total Debt Repaid | - | - | - | -4 | -1.55 |
Net Debt Issued (Repaid) | 6 | - | - | - | -0.84 |
Issuance of Common Stock | 5.93 | 17.11 | 0.11 | - | 32.5 |
Repurchase of Common Stock | - | - | -0.28 | -3.27 | - |
Common Dividends Paid | - | -0.72 | -0.74 | - | - |
Other Financing Activities | -0.68 | -0.96 | - | - | -2.02 |
Financing Cash Flow | 11.25 | 15.43 | -0.91 | -3.27 | 29.64 |
Foreign Exchange Rate Adjustments | 0.71 | -1.07 | 0.52 | 1.6 | -0.47 |
Net Cash Flow | -7.84 | -3.62 | -30.03 | 8.41 | -18.36 |
Free Cash Flow | -20.77 | -29.45 | -20.17 | -26.7 | -35.79 |
Free Cash Flow Margin | -100.28% | -103.19% | -59.54% | -61.94% | -118.63% |
Free Cash Flow Per Share | -1.12 | -1.92 | -1.51 | -1.96 | -2.63 |
Cash Interest Paid | 0 | - | - | 0.06 | 0.04 |
Cash Income Tax Paid | - | - | 1.81 | - | - |
Levered Free Cash Flow | -0.65 | -15.22 | -13.72 | -17.45 | -27.29 |
Unlevered Free Cash Flow | -0.13 | -14.67 | -13.71 | -17.41 | -27.29 |
Change in Working Capital | 18.5 | 0.77 | -7.82 | -6.65 | -3.22 |